Cargando…
miR-144-3p inhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2A
Multiple myelomas (MM) are the second most common haematological malignancy, for which no curative treatments have been reported to date. MicroRNAs (miRNAs or miRs) have recently been shown to be involved in the proliferation of MM cells. However, the molecular mechanisms through which miRNAs regula...
Autores principales: | Tian, Fei, Wang, Huihan, Ma, Huanxin, Zhong, Yuan, Liao, Aijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387096/ https://www.ncbi.nlm.nih.gov/pubmed/32705159 http://dx.doi.org/10.3892/ijmm.2020.4670 |
Ejemplares similares
-
PIWI-Interacting RNA-004800 Is Regulated by S1P Receptor Signaling Pathway to Keep Myeloma Cell Survival
por: Ma, Huanxin, et al.
Publicado: (2020) -
Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma
por: Peng, Ya-Guang, et al.
Publicado: (2017) -
MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4
por: Yu, Min, et al.
Publicado: (2016) -
miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1
por: Han, Shichao, et al.
Publicado: (2018) -
Retracted: miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1
por: Han, Shichao, et al.
Publicado: (2018)